Surmodics, Inc. (SRDX)

32.49 -2.06 (-5.96%) 收市：04:00PM EDT

Surmodics, Inc.

9924 West 74th Street
Eden Prairie, MN 55344-3523
United States
952 500 7000
https://www.surmodics.com

版塊: Healthcare
行業: Medical Devices
全職員工: 376

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Gary R. Maharaj	CEO, President & Director	1.33M	無	1963
Mr. Timothy J. Arens	Senior VP of Finance & Information Technology and CFO	645.3k	59.73k	1967
Mr. Gordon S. Weber	Senior VP of Legal, General Counsel & Secretary	602.84k	無	1963
Mr. Charles W. Olson	Senior VP & President of Medical Device Coatings	618.47k	無	1964
Ms. Teryl L. W. Sides	Senior VP & President of Vascular Interventions	744.38k	無	1970
Mr. John D. Manders	Corporate Controller, VP of Finance & Principal Accounting Officer	無	無	1981
Mr. Joseph J. Stich	Senior VP of Human Resources & President of In Vitro Diagnostics	570.92k	501.23k	1965

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

公司管治

截至 2024年5月1日 止，Surmodics, Inc. 的 ISS 管治質素評分為 4。 Pillar 分數正在審核中：6；董事會：2；股東權利：5；現金賠償：5。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。